AVIR
NASDAQStockAtea Pharmaceuticals, Inc.
$6.09-0.01 (-0.16%)
52-Week Range
$2.55
$6.15
Key Stats
Market Cap
475.8M
P/E Ratio
—
Dividend Yield
—
Beta
0.26
Volume
367.8K
Avg Volume
697.3K
Performance
1M
+40.88%
3M
+93.65%
6M
+100.66%
YTD
+75.29%
1Y
+98.05%
3Y
+67.12%
5Y
-91.26%
Price Chart
ETF Exposure
AVIR is held by 62 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GERM | ETFMG Treatments, Testing and Advancements ETF | 0.66% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.32% |
| IWC | iShares Micro-Cap ETF | 0.09% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.04% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.04% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.02% |
| PKW | Invesco BuyBack Achievers ETF | 0.02% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.02% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.01% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.01% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.01% |
| STSB | iShares Factors US Small Blend Style ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| VHT | Vanguard Health Care ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| VALT | ETFMG Sit Ultra Short ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DFAT | Dimensional - US Targeted Value ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
Page 1 of 2Next
About AVIR ETF Exposure
Atea Pharmaceuticals, Inc. (AVIR) is held by 62 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 475.8M, AVIR is a widely held institutional stock. The stock currently trades at $6.09. Investors can gain exposure to AVIR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AVIR, sorted by portfolio weight.